Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane PK in ARDS Morphotypes
NCT04023305Terminated
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Feb 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sevoflurane in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Plasma concentrations of sevoflurane. Started Feb 2020; status: terminated.
02
Drugs
sevoflurane
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04023305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04023305.